List/Grid Tag Archives: hepatitis d
Maxwell Biotech Venture Fund Invests in Myrcludex B
Reuters: Tue Mar 20, 2012 11:30am EDT Maxwell Biotech Venture Fund Invests in Hepatitis B/D Clinical Program Co-Invests with Germany’s Public/Private High-Tech Gründerfonds, One of Europe’s Top Venture Funds Maxwell…
Hepatitis B Affects 2 Billion – WHO
Leadership Newspapers Hepatitis B Affects 2 Billion – WHO Leadership Newspapers WHO has identified five main hepatitis viruses, referred to as types A, B, C, D and E . These five types, according to the organisation, are of greatest concern because of the burden of illness and death they cause and the potential for outbreaks and … and more »
Vitamin D May Be the Answer to Common Liver Diseases Like Hepatitis C
Vitamin D May Be the Answer to Common Liver Diseases Like Hepatitis C and … SBWire (press release) San Francisco, CA — (SBWIRE) — 01/26/2012 — The promising research shows the Vitamin D (which can be taken orally in tablet form) can essentially halt many viruses and in particular it can halt the Hepatitis C virus. In a healthy liver, Vitamin D …
168 People Infected with Hepatitis C – CRIENGLISH.com
CRIENGLISH.com 168 People Infected with Hepatitis C CRIENGLISH.com The mother of a child suspected of being infected with the Hepatitis C virus shows the laboratory test report from the First Hospital affiliated with Anhui Medical University in Hefei, provincial capital city of Anhui province, November 29, 2011. … China clinic blamed for Hepatitis C outbreak Channel News Asia Recycled needles spread hepatitis C AsiaOne Six more found infected after Hepatitis C outbreak in central China Xinhua New York Daily News all 141 news articles »
World Hepatitis Day brings in Red Door Communications for two-year brief – PRWeek UK
World Hepatitis Day brings in Red Door Communications for two-year brief PRWeek UK The World Hepatitis Alliance (WHA) has handed Red Door Communications a £450000 brief to co-ordinate its World Hepatitis Day campaigns for the next two years. Red Door has been asked to raise awareness of chronic viral hepatitis B and C through a …
Gilead to Acquire Pharmasset for $11 Billion to Add Hepatitis C Medicines – Bloomberg
Bloomberg Gilead to Acquire Pharmasset for $11 Billion to Add Hepatitis C Medicines Bloomberg Photographer: David Paul Morris/Bloomberg Gilead Sciences Inc. (GILD), the world's largest maker of HIV medicines, agreed to buy Pharmasset Inc. (VRUS) for about $11 billion, betting that its experimental hepatitis C treatments will lead the next … Gilead Sciences agrees to pay $11 billion for hepatitis C drug developer … Washington Post Pharmasset Acquisition Elevates Gilead's Hepatitis C Pipeline, But at a Steep … Toronto Star What's Next for Hep C Drug Stocks Following Gilead's $11B Pharmasset Buy? TheStreet.com AIDSmeds.com HIV/AIDS Treatment News - DailyFinance all 547 news articles »
Recent Comments